Network meta-analysis of intravitreal conbercept as an adjuvant to vitrectomy for proliferative diabetic retinopathy

被引:1
|
作者
Wang, Weiwei [1 ]
Qu, Chaoyi [1 ]
Yan, Huanhuan [1 ]
机构
[1] Xian Peoples Hosp, Shaanxi Eye Hosp, Xian Hosp 4, Xian, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词
proliferative diabetic retinopathy; vitrectomy; conbercept; intravitreal; network meta-analysis; PARS-PLANA VITRECTOMY; LINEAR MIXED MODELS; SYSTEMATIC REVIEWS; HEALTH-CARE; INCONSISTENCY; BEVACIZUMAB; PRETREATMENT; RANIBIZUMAB;
D O I
10.3389/fendo.2023.1098165
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeIntravitreal Conbercept (IVC) has been shown to be effective in treating proliferative diabetic retinopathy (PDR) as an adjuvant in pars plana vitrectomy (PPV); however, the best timing of IVC injection remains unknown. This network meta-analysis (NMA) sought to ascertain the comparative efficacy of different timings of IVC injection as an adjuvant to PPV on PDR. MethodsA comprehensive literature search was conducted in PubMed, EMBASE, and the Cochrane Library to identify relevant studies published before August 11, 2022. According to the mean time of IVC injection before PPV, the strategy was defined as very long interval if it was > 7 days but <= 9 days, long interval if it was > 5 days but <= 7 days, mid interval if it was > 3 days but <= 5 days, and short interval if it was <= 3 days, respectively. The strategy was defined as perioperative IVC if IVC was injected both before and at the end of PPV, and the strategy was intraoperative IVC if injected immediately at the end of PPV. The mean difference (MD) and odds ratio (OR) with corresponding 95% confidence interval (CI) for continuous and binary variables, respectively, were computed through network meta-analysis using Stata 14.0 MP. ResultsEighteen studies involving 1149 patients were included. There was no statistical difference between intraoperative IVC and control in treating PDR. Except for a very long interval, preoperative IVC significantly shortened operation time, and reduced intraoperative bleeding and iatrogenic retinal breaks. Long and short intervals reduced endodiathermy application, and mid and short intervals reduced postoperative vitreous hemorrhage. Moreover, long and mid intervals improved BCVA and central macular thickness. However, very long interval was associated with an increased risk of postoperative vitreous hemorrhage (RR: 3.27, 95%CI: 1.84 to 5.83). Moreover, mid interval was better than intraoperative IVC in shortening operation time (MD: -19.74, 95%CI: -33.31 to -6.17). ConclusionsThere are no discernible effects of intraoperative IVC on PDR, but preoperative IVC, except for very long interval, is an effective adjuvant to PPV for treating PDR.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A systematic review and meta-analysis of clinical outcomes of vitrectomy with or without intravitreal bevacizumab pretreatment for severe diabetic retinopathy
    Zhao, Li-Quan
    Zhu, Huang
    Zhao, Pei-Quan
    Hu, Yi-Qian
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (09) : 1216 - 1222
  • [42] Refining vitrectomy for proliferative diabetic retinopathy
    San-Ni Chen
    Shih-Jen Chen
    Tsung-Tien Wu
    Wei-Chi Wu
    Chang-Hao Yang
    Chung-May Yang
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2023, 261 : 3659 - 3670
  • [43] Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy
    Hu, Liting
    Chen, Qiulu
    Du, Zhaodong
    Wang, Wenying
    Zhao, Guiqiu
    INTERNATIONAL OPHTHALMOLOGY, 2021, 41 (05) : 1635 - 1642
  • [44] Evaluation of vitrectomy combined preoperative intravitreal ranibizumab and postoperative intravitreal triamcinolone acetonide for proliferative diabetic retinopathy
    Liting Hu
    Qiulu Chen
    Zhaodong Du
    Wenying Wang
    Guiqiu Zhao
    International Ophthalmology, 2021, 41 : 1635 - 1642
  • [45] Early vitrectomy for proliferative diabetic retinopathy
    Hori, S
    Kato, S
    Masuzawa, K
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1731 - 1736
  • [46] Clinical efficacy and acceptability of panretinal photocoagulation combined with conbercept for patients with proliferative diabetic retinopathy A protocol for systematic review and meta-analysis
    Wang, Liangyu
    Chen, Zhaoli
    Wang, Xiaoxue
    MEDICINE, 2021, 100 (17) : E25611
  • [47] Vitrectomy results in proliferative diabetic retinopathy
    Luan, Jie
    Ando, Fumitaka
    Hirose, Hirosi
    Yasui, Osumu
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2008, 1 (04): : 356 - 358
  • [48] Vitrectomy and proliferative diabetic retinopathy.
    Bouchard, O
    Zech, JC
    Trepsat, C
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 1997, 20 (04): : 263 - 270
  • [49] VITRECTOMY IN THE PROLIFERATIVE DIABETIC-RETINOPATHY
    PAVLOVIC, S
    IGNJACEV, M
    LATINOVIC, S
    TOMIC, Z
    OPHTHALMOLOGY TODAY, 1988, 803 : 553 - 554
  • [50] Refining vitrectomy for proliferative diabetic retinopathy
    Chen, San-Ni
    Chen, Shih-Jen
    Wu, Tsung-Tien
    Wu, Wei-Chi
    Yang, Chang-Hao
    Yang, Chung-May
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (12) : 3659 - 3670